Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 318555011000036117 | levodopa 100 mg + benserazide 25 mg modified release capsule, 100 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 318556011000036112 | benserazide 25 mg + levodopa 100 mg modified release capsule, 100 capsules (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| levodopa 100 mg + benserazide 25 mg modified release capsule, 100 | has MPUU | levodopa 100 mg + benserazide 25 mg modified release capsule | true | Inferred relationship | Some | 1 | |
| levodopa 100 mg + benserazide 25 mg modified release capsule, 100 | Is a | levodopa 100 mg + benserazide 25 mg capsule, 100 | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Madopar HBS 100/25 modified release capsule, 100 | Is a | True | levodopa 100 mg + benserazide 25 mg modified release capsule, 100 | Inferred relationship | Some |
Reference Sets
List of Medicines for Brand Consideration reference set
Australian dialect reference set
Medicinal product pack reference set
FHIR